Mus musculus (house mouse): 18033
Help
Entry
18033 CDS
T01002
Symbol
Nfkb1, NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105
Name
(RefSeq) nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
KO
K02580
nuclear factor NF-kappa-B p105 subunit
Organism
mmu
Mus musculus (house mouse)
Pathway
mmu01523
Antifolate resistance
mmu04010
MAPK signaling pathway
mmu04014
Ras signaling pathway
mmu04024
cAMP signaling pathway
mmu04062
Chemokine signaling pathway
mmu04064
NF-kappa B signaling pathway
mmu04066
HIF-1 signaling pathway
mmu04071
Sphingolipid signaling pathway
mmu04151
PI3K-Akt signaling pathway
mmu04210
Apoptosis
mmu04211
Longevity regulating pathway
mmu04218
Cellular senescence
mmu04380
Osteoclast differentiation
mmu04613
Neutrophil extracellular trap formation
mmu04620
Toll-like receptor signaling pathway
mmu04621
NOD-like receptor signaling pathway
mmu04622
RIG-I-like receptor signaling pathway
mmu04623
Cytosolic DNA-sensing pathway
mmu04625
C-type lectin receptor signaling pathway
mmu04657
IL-17 signaling pathway
mmu04658
Th1 and Th2 cell differentiation
mmu04659
Th17 cell differentiation
mmu04660
T cell receptor signaling pathway
mmu04662
B cell receptor signaling pathway
mmu04668
TNF signaling pathway
mmu04722
Neurotrophin signaling pathway
mmu04917
Prolactin signaling pathway
mmu04920
Adipocytokine signaling pathway
mmu04926
Relaxin signaling pathway
mmu04931
Insulin resistance
mmu04932
Non-alcoholic fatty liver disease
mmu04933
AGE-RAGE signaling pathway in diabetic complications
mmu04936
Alcoholic liver disease
mmu05010
Alzheimer disease
mmu05022
Pathways of neurodegeneration - multiple diseases
mmu05030
Cocaine addiction
mmu05132
Salmonella infection
mmu05133
Pertussis
mmu05134
Legionellosis
mmu05135
Yersinia infection
mmu05140
Leishmaniasis
mmu05142
Chagas disease
mmu05145
Toxoplasmosis
mmu05146
Amoebiasis
mmu05152
Tuberculosis
mmu05160
Hepatitis C
mmu05161
Hepatitis B
mmu05162
Measles
mmu05163
Human cytomegalovirus infection
mmu05164
Influenza A
mmu05165
Human papillomavirus infection
mmu05166
Human T-cell leukemia virus 1 infection
mmu05167
Kaposi sarcoma-associated herpesvirus infection
mmu05168
Herpes simplex virus 1 infection
mmu05169
Epstein-Barr virus infection
mmu05170
Human immunodeficiency virus 1 infection
mmu05171
Coronavirus disease - COVID-19
mmu05200
Pathways in cancer
mmu05202
Transcriptional misregulation in cancer
mmu05203
Viral carcinogenesis
mmu05206
MicroRNAs in cancer
mmu05207
Chemical carcinogenesis - receptor activation
mmu05208
Chemical carcinogenesis - reactive oxygen species
mmu05212
Pancreatic cancer
mmu05215
Prostate cancer
mmu05220
Chronic myeloid leukemia
mmu05221
Acute myeloid leukemia
mmu05222
Small cell lung cancer
mmu05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
mmu05321
Inflammatory bowel disease
mmu05415
Diabetic cardiomyopathy
mmu05417
Lipid and atherosclerosis
mmu05418
Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
mmu00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
18033 (Nfkb1)
04014 Ras signaling pathway
18033 (Nfkb1)
04064 NF-kappa B signaling pathway
18033 (Nfkb1)
04668 TNF signaling pathway
18033 (Nfkb1)
04066 HIF-1 signaling pathway
18033 (Nfkb1)
04071 Sphingolipid signaling pathway
18033 (Nfkb1)
04024 cAMP signaling pathway
18033 (Nfkb1)
04151 PI3K-Akt signaling pathway
18033 (Nfkb1)
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
18033 (Nfkb1)
04218 Cellular senescence
18033 (Nfkb1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
18033 (Nfkb1)
04620 Toll-like receptor signaling pathway
18033 (Nfkb1)
04621 NOD-like receptor signaling pathway
18033 (Nfkb1)
04622 RIG-I-like receptor signaling pathway
18033 (Nfkb1)
04623 Cytosolic DNA-sensing pathway
18033 (Nfkb1)
04625 C-type lectin receptor signaling pathway
18033 (Nfkb1)
04660 T cell receptor signaling pathway
18033 (Nfkb1)
04658 Th1 and Th2 cell differentiation
18033 (Nfkb1)
04659 Th17 cell differentiation
18033 (Nfkb1)
04657 IL-17 signaling pathway
18033 (Nfkb1)
04662 B cell receptor signaling pathway
18033 (Nfkb1)
04062 Chemokine signaling pathway
18033 (Nfkb1)
09152 Endocrine system
04920 Adipocytokine signaling pathway
18033 (Nfkb1)
04917 Prolactin signaling pathway
18033 (Nfkb1)
04926 Relaxin signaling pathway
18033 (Nfkb1)
09156 Nervous system
04722 Neurotrophin signaling pathway
18033 (Nfkb1)
09158 Development and regeneration
04380 Osteoclast differentiation
18033 (Nfkb1)
09149 Aging
04211 Longevity regulating pathway
18033 (Nfkb1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
18033 (Nfkb1)
05202 Transcriptional misregulation in cancer
18033 (Nfkb1)
05206 MicroRNAs in cancer
18033 (Nfkb1)
05207 Chemical carcinogenesis - receptor activation
18033 (Nfkb1)
05208 Chemical carcinogenesis - reactive oxygen species
18033 (Nfkb1)
05203 Viral carcinogenesis
18033 (Nfkb1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
18033 (Nfkb1)
09162 Cancer: specific types
05212 Pancreatic cancer
18033 (Nfkb1)
05221 Acute myeloid leukemia
18033 (Nfkb1)
05220 Chronic myeloid leukemia
18033 (Nfkb1)
05215 Prostate cancer
18033 (Nfkb1)
05222 Small cell lung cancer
18033 (Nfkb1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
18033 (Nfkb1)
05170 Human immunodeficiency virus 1 infection
18033 (Nfkb1)
05161 Hepatitis B
18033 (Nfkb1)
05160 Hepatitis C
18033 (Nfkb1)
05171 Coronavirus disease - COVID-19
18033 (Nfkb1)
05164 Influenza A
18033 (Nfkb1)
05162 Measles
18033 (Nfkb1)
05168 Herpes simplex virus 1 infection
18033 (Nfkb1)
05163 Human cytomegalovirus infection
18033 (Nfkb1)
05167 Kaposi sarcoma-associated herpesvirus infection
18033 (Nfkb1)
05169 Epstein-Barr virus infection
18033 (Nfkb1)
05165 Human papillomavirus infection
18033 (Nfkb1)
09171 Infectious disease: bacterial
05132 Salmonella infection
18033 (Nfkb1)
05135 Yersinia infection
18033 (Nfkb1)
05133 Pertussis
18033 (Nfkb1)
05134 Legionellosis
18033 (Nfkb1)
05152 Tuberculosis
18033 (Nfkb1)
09174 Infectious disease: parasitic
05146 Amoebiasis
18033 (Nfkb1)
05145 Toxoplasmosis
18033 (Nfkb1)
05140 Leishmaniasis
18033 (Nfkb1)
05142 Chagas disease
18033 (Nfkb1)
09163 Immune disease
05321 Inflammatory bowel disease
18033 (Nfkb1)
09164 Neurodegenerative disease
05010 Alzheimer disease
18033 (Nfkb1)
05022 Pathways of neurodegeneration - multiple diseases
18033 (Nfkb1)
09165 Substance dependence
05030 Cocaine addiction
18033 (Nfkb1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
18033 (Nfkb1)
05418 Fluid shear stress and atherosclerosis
18033 (Nfkb1)
05415 Diabetic cardiomyopathy
18033 (Nfkb1)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
18033 (Nfkb1)
04932 Non-alcoholic fatty liver disease
18033 (Nfkb1)
04931 Insulin resistance
18033 (Nfkb1)
04933 AGE-RAGE signaling pathway in diabetic complications
18033 (Nfkb1)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
18033 (Nfkb1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:
mmu03000
]
18033 (Nfkb1)
Transcription factors [BR:
mmu03000
]
Eukaryotic type
beta-Scaffold factors with minor groove contacts
RHR (Rel homology region) Rel/Ankyrin
18033 (Nfkb1)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
RHD_DNA_bind
RHD_dimer
Ank_2
Ank
Ank_4
Ank_3
Ank_5
Death
Motif
Other DBs
NCBI-GeneID:
18033
NCBI-ProteinID:
NP_032715
MGI:
97312
Ensembl:
ENSMUSG00000028163
UniProt:
P25799
Structure
PDB
LinkDB
All DBs
Position
3:complement(135290416..135397422)
Genome browser
AA seq
971 aa
AA seq
DB search
MADDDPYGTGQMFHLNTALTHSIFNAELYSPEIPLSTDGPYLQILEQPKQRGFRFRYVCE
GPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGV
CTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHSDLAYLQAEG
GGDRQLTDREKEIIRQAAVQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDS
KAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSP
TDVHRQFAIVFKTPKYKDVNITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRK
RQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGSTGSPGPGYGYSNYGFPPYGGITFHPG
VTKSNAGVTHGTINTKFKNGPKDCAKSDDEESLTLPEKETEGEGPSLPMACTKTEPIALA
STMEDKEQDMGFQDNLFLEKALQLARRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGD
SVLHLAIIHLHAQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRV
GADLSLLDRWGNSVLHLAAKEGHDRILSILLKSRKAAPLIDHPNGEGLNAIHIAVMSNSL
PCLLLLVAAGAEVNAQEQKSGRTALHLAVEYDNISLAGCLLLEGDAHVDSTTYDGTTPLH
IAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWEKAGEDEGVVPGTTPLDMAANWQV
FDILNGKPYEPVFTSDDILPQGDMKQLTEDTRLQLCKLLEIPDPDKNWATLAQKLGLGIL
NNAFRLSPAPSKTLMDNYEVSGGTIKELMEALQQMGYTEAIEVIQAAFRTPATTASSPVT
TAQVHCLPLSSSSTRQHIDELRDSDSVCDSGVETSFRKLSFTESLTGDSPLLSLNKMPHG
YGQEGPIEGKI
NT seq
2916 nt
NT seq
+upstream
nt +downstream
nt
atggcagacgatgatccctacggaactgggcaaatgtttcatttgaacactgctttgact
cactcaatatttaatgcagaattatattcaccagaaataccactgtcaacagatggccca
taccttcaaatattagagcaaccaaaacagaggggatttcgattccgctatgtgtgtgaa
ggcccatcacacggagggcttccgggagcctctagtgagaagaacaagaaatcctaccca
caggtcaaaatttgcaactatgtggggcctgcaaaggttatcgttcagttggtcacaaat
ggaaaaaacatccacctgcacgcccacagcctggtgggcaagcactgtgaggacggggta
tgcaccgtaacagcaggacccaaggacatggtggttggctttgcaaacctgggaatactt
catgtgactaagaaaaaggtatttgaaacactggaagcacggatgacagaggcgtgtatt
aggggctataatcctggacttctggtgcattctgaccttgcctatctacaagcagaaggc
ggaggagaccggcaactcacagacagagagaaggagatcatccgccaggcagccgtgcag
cagaccaaggagatggacctgagcgtggtgcgcctcatgttcacagccttcctccctgac
agcactggcagcttcactcggagactggagcctgtggtgtcagacgccatctatgatagc
aaagccccgaatgcatccaacctgaaaatcgtgagaatggacagaacagcaggatgtgtg
acgggaggggaggagatttaccttctctgtgacaaggttcagaaagatgacatccagatt
cggttttatgaagaggaagaaaatggcggagtttgggaaggatttggggacttttccccc
acagatgttcatagacagtttgccattgtcttcaaaacgccaaagtataaggatgtcaac
attacaaagccagcttccgtgtttgttcagcttcggaggaaatcagacctggaaactagt
gaaccgaaaccctttctctactaccctgaaatcaaagacaaagaggaagtgcaaaggaaa
cgccagaagcttatgccgaacttctcggacagcttcggtggcggcagtggagcgggagcc
ggtggtggaggcatgttcggtagtggcggtggcggagggagtaccggaagccctggccca
gggtatggctactcgaactacggatttcctccctacggtgggattacattccatcccgga
gtcacgaaatccaacgcaggggtcacccatggcaccataaacaccaaatttaaaaatggc
cctaaagattgtgccaagagtgatgacgaggagagtctgactctccctgagaaggaaact
gaaggtgaagggcccagcctgcccatggcctgcaccaagacggaacccatcgccttggca
tccaccatggaagacaaggagcaggacatgggatttcaggataacctctttcttgagaag
gctctgcagctcgccaggcgacacgccaacgcccttttcgactacgcagtgacgggggat
gtgaagatgttgctggccgtgcaacgccatctcaccgccgtgcaggatgagaatggggac
agtgtcttacacttagccatcatccacctccacgctcagcttgtgagggatctgctggaa
gtcacatctggtttgatctctgatgacatcatcaacatgagaaatgacctgtatcagaca
cctctgcacttggccgtgatcaccaagcaggaagatgtagtagaggatttgctgagggtt
ggggctgacctgagccttctggaccgctggggcaactctgtcctgcacctagctgccaaa
gaaggacacgacagaatcctcagcatcctgctcaagagcagaaaagcagcgccccttatc
gaccaccccaatggggaaggtctaaatgccatccacatagctgtgatgagcaatagcctg
ccatgtctgctgctgctggtggctgccggggcagaagtcaatgctcaggagcagaagtct
gggcgcacagcgctgcacctggccgtggagtacgacaacatctccttggctggctgcctg
cttctggagggtgatgcccacgtggacagtaccacctatgatgggactacacctctgcat
atagcggccggaagagggtccaccagactggcagctcttctcaaagcagcaggagcagac
cccctggtggagaactttgagcctctctatgacctggacgactcttgggagaaggctgga
gaagatgagggagtggtgccaggtaccacacccctggacatggctgccaactggcaggta
tttgacatactaaatgggaaaccgtatgagcctgtgttcacatctgatgatatactacca
caaggggacatgaagcagctgacagaagacacgaggctacaactctgcaaactgctggaa
attcctgatccagacaaaaactgggccactctggcacagaagttgggtctggggatactg
aacaatgccttccggctgagtcctgctccttctaaaactctcatggacaactatgaggtc
tctgggggtaccatcaaagagctgatggaggccctgcaacagatgggctacacagaggcc
attgaagtgatccaggcagccttccgcaccccggcaaccacagcctccagccccgtgacc
actgctcaggtccactgtctgcctctctcgtcttcctccacgaggcagcacatagatgaa
ctccgggatagtgacagcgtctgtgacagtggtgtggagacatccttccgcaaactcagc
tttacagagtctcttactggagacagcccactgctatctctgaacaaaatgccccacggt
tatgggcaggaaggacctattgaaggcaaaatttag
Mus musculus (house mouse): 19697
Help
Entry
19697 CDS
T01002
Symbol
Rela, p65, p65_NF-kappa_B, p65_NFkB
Name
(RefSeq) v-rel reticuloendotheliosis viral oncogene homolog A (avian)
KO
K04735
transcription factor p65
Organism
mmu
Mus musculus (house mouse)
Pathway
mmu01523
Antifolate resistance
mmu04010
MAPK signaling pathway
mmu04014
Ras signaling pathway
mmu04024
cAMP signaling pathway
mmu04062
Chemokine signaling pathway
mmu04064
NF-kappa B signaling pathway
mmu04066
HIF-1 signaling pathway
mmu04071
Sphingolipid signaling pathway
mmu04137
Mitophagy - animal
mmu04151
PI3K-Akt signaling pathway
mmu04210
Apoptosis
mmu04211
Longevity regulating pathway
mmu04218
Cellular senescence
mmu04380
Osteoclast differentiation
mmu04613
Neutrophil extracellular trap formation
mmu04620
Toll-like receptor signaling pathway
mmu04621
NOD-like receptor signaling pathway
mmu04622
RIG-I-like receptor signaling pathway
mmu04623
Cytosolic DNA-sensing pathway
mmu04625
C-type lectin receptor signaling pathway
mmu04657
IL-17 signaling pathway
mmu04658
Th1 and Th2 cell differentiation
mmu04659
Th17 cell differentiation
mmu04660
T cell receptor signaling pathway
mmu04662
B cell receptor signaling pathway
mmu04668
TNF signaling pathway
mmu04722
Neurotrophin signaling pathway
mmu04917
Prolactin signaling pathway
mmu04920
Adipocytokine signaling pathway
mmu04926
Relaxin signaling pathway
mmu04931
Insulin resistance
mmu04932
Non-alcoholic fatty liver disease
mmu04933
AGE-RAGE signaling pathway in diabetic complications
mmu04936
Alcoholic liver disease
mmu05010
Alzheimer disease
mmu05022
Pathways of neurodegeneration - multiple diseases
mmu05030
Cocaine addiction
mmu05132
Salmonella infection
mmu05133
Pertussis
mmu05134
Legionellosis
mmu05135
Yersinia infection
mmu05140
Leishmaniasis
mmu05142
Chagas disease
mmu05145
Toxoplasmosis
mmu05146
Amoebiasis
mmu05152
Tuberculosis
mmu05160
Hepatitis C
mmu05161
Hepatitis B
mmu05162
Measles
mmu05163
Human cytomegalovirus infection
mmu05164
Influenza A
mmu05165
Human papillomavirus infection
mmu05166
Human T-cell leukemia virus 1 infection
mmu05167
Kaposi sarcoma-associated herpesvirus infection
mmu05168
Herpes simplex virus 1 infection
mmu05169
Epstein-Barr virus infection
mmu05170
Human immunodeficiency virus 1 infection
mmu05171
Coronavirus disease - COVID-19
mmu05200
Pathways in cancer
mmu05202
Transcriptional misregulation in cancer
mmu05203
Viral carcinogenesis
mmu05207
Chemical carcinogenesis - receptor activation
mmu05208
Chemical carcinogenesis - reactive oxygen species
mmu05212
Pancreatic cancer
mmu05215
Prostate cancer
mmu05220
Chronic myeloid leukemia
mmu05221
Acute myeloid leukemia
mmu05222
Small cell lung cancer
mmu05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
mmu05321
Inflammatory bowel disease
mmu05415
Diabetic cardiomyopathy
mmu05417
Lipid and atherosclerosis
mmu05418
Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
mmu00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
19697 (Rela)
04014 Ras signaling pathway
19697 (Rela)
04064 NF-kappa B signaling pathway
19697 (Rela)
04668 TNF signaling pathway
19697 (Rela)
04066 HIF-1 signaling pathway
19697 (Rela)
04071 Sphingolipid signaling pathway
19697 (Rela)
04024 cAMP signaling pathway
19697 (Rela)
04151 PI3K-Akt signaling pathway
19697 (Rela)
09140 Cellular Processes
09141 Transport and catabolism
04137 Mitophagy - animal
19697 (Rela)
09143 Cell growth and death
04210 Apoptosis
19697 (Rela)
04218 Cellular senescence
19697 (Rela)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
19697 (Rela)
04620 Toll-like receptor signaling pathway
19697 (Rela)
04621 NOD-like receptor signaling pathway
19697 (Rela)
04622 RIG-I-like receptor signaling pathway
19697 (Rela)
04623 Cytosolic DNA-sensing pathway
19697 (Rela)
04625 C-type lectin receptor signaling pathway
19697 (Rela)
04660 T cell receptor signaling pathway
19697 (Rela)
04658 Th1 and Th2 cell differentiation
19697 (Rela)
04659 Th17 cell differentiation
19697 (Rela)
04657 IL-17 signaling pathway
19697 (Rela)
04662 B cell receptor signaling pathway
19697 (Rela)
04062 Chemokine signaling pathway
19697 (Rela)
09152 Endocrine system
04920 Adipocytokine signaling pathway
19697 (Rela)
04917 Prolactin signaling pathway
19697 (Rela)
04926 Relaxin signaling pathway
19697 (Rela)
09156 Nervous system
04722 Neurotrophin signaling pathway
19697 (Rela)
09158 Development and regeneration
04380 Osteoclast differentiation
19697 (Rela)
09149 Aging
04211 Longevity regulating pathway
19697 (Rela)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
19697 (Rela)
05202 Transcriptional misregulation in cancer
19697 (Rela)
05207 Chemical carcinogenesis - receptor activation
19697 (Rela)
05208 Chemical carcinogenesis - reactive oxygen species
19697 (Rela)
05203 Viral carcinogenesis
19697 (Rela)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
19697 (Rela)
09162 Cancer: specific types
05212 Pancreatic cancer
19697 (Rela)
05221 Acute myeloid leukemia
19697 (Rela)
05220 Chronic myeloid leukemia
19697 (Rela)
05215 Prostate cancer
19697 (Rela)
05222 Small cell lung cancer
19697 (Rela)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
19697 (Rela)
05170 Human immunodeficiency virus 1 infection
19697 (Rela)
05161 Hepatitis B
19697 (Rela)
05160 Hepatitis C
19697 (Rela)
05171 Coronavirus disease - COVID-19
19697 (Rela)
05164 Influenza A
19697 (Rela)
05162 Measles
19697 (Rela)
05168 Herpes simplex virus 1 infection
19697 (Rela)
05163 Human cytomegalovirus infection
19697 (Rela)
05167 Kaposi sarcoma-associated herpesvirus infection
19697 (Rela)
05169 Epstein-Barr virus infection
19697 (Rela)
05165 Human papillomavirus infection
19697 (Rela)
09171 Infectious disease: bacterial
05132 Salmonella infection
19697 (Rela)
05135 Yersinia infection
19697 (Rela)
05133 Pertussis
19697 (Rela)
05134 Legionellosis
19697 (Rela)
05152 Tuberculosis
19697 (Rela)
09174 Infectious disease: parasitic
05146 Amoebiasis
19697 (Rela)
05145 Toxoplasmosis
19697 (Rela)
05140 Leishmaniasis
19697 (Rela)
05142 Chagas disease
19697 (Rela)
09163 Immune disease
05321 Inflammatory bowel disease
19697 (Rela)
09164 Neurodegenerative disease
05010 Alzheimer disease
19697 (Rela)
05022 Pathways of neurodegeneration - multiple diseases
19697 (Rela)
09165 Substance dependence
05030 Cocaine addiction
19697 (Rela)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
19697 (Rela)
05418 Fluid shear stress and atherosclerosis
19697 (Rela)
05415 Diabetic cardiomyopathy
19697 (Rela)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
19697 (Rela)
04932 Non-alcoholic fatty liver disease
19697 (Rela)
04931 Insulin resistance
19697 (Rela)
04933 AGE-RAGE signaling pathway in diabetic complications
19697 (Rela)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
19697 (Rela)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:
mmu03000
]
19697 (Rela)
Transcription factors [BR:
mmu03000
]
Eukaryotic type
beta-Scaffold factors with minor groove contacts
RHR (Rel homology region) Rel/Ankyrin
19697 (Rela)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
RHD_DNA_bind
RHD_dimer
Motif
Other DBs
NCBI-GeneID:
19697
NCBI-ProteinID:
NP_033071
MGI:
103290
Ensembl:
ENSMUSG00000024927
UniProt:
Q04207
Q548Y4
Structure
PDB
LinkDB
All DBs
Position
19:5686993..5698162
Genome browser
AA seq
549 aa
AA seq
DB search
MDDLFPLIFPSEPAQASGPYVEIIEQPKQRGMRFRYKCEGRSAGSIPGERSTDTTKTHPT
IKINGYTGPGTVRISLVTKDPPHRPHPHELVGKDCRDGYYEADLCPDRSIHSFQNLGIQC
VKKRDLEQAISQRIQTNNNPFHVPIEEQRGDYDLNAVRLCFQVTVRDPAGRPLLLTPVLS
HPIFDNRAPNTAELKICRVNRNSGSCLGGDEIFLLCDKVQKEDIEVYFTGPGWEARGSFS
QADVHRQVAIVFRTPPYADPSLQAPVRVSMQLRRPSDRELSEPMEFQYLPDTDDRHRIEE
KRKRTYETFKSIMKKSPFNGPTEPRPPTRRIAVPTRNSTSVPKPAPQPYTFPASLSTINF
DEFSPMLLPSGQISNQALALAPSSAPVLAQTMVPSSAMVPLAQPPAPAPVLTPGPPQSLS
APVPKSTQAGEGTLSEALLHLQFDADEDLGALLGNSTDPGVFTDLASVDNSEFQQLLNQG
VSMSHSTAEPMLMEYPEAITRLVTGSQRPPDPAPTPLGTSGLPNGLSGDEDFSSIADMDF
SALLSQISS
NT seq
1650 nt
NT seq
+upstream
nt +downstream
nt
atggacgatctgtttcccctcatctttccctcagagccagcccaggcttctgggccttat
gtggagatcatcgaacagccgaagcaacggggcatgcgattccgctataaatgcgagggg
cgctcagcgggcagtattcctggcgagagaagcacagataccaccaagacacaccccacc
atcaagatcaatggctacacaggaccaggaacagttcgaatctccctggtcaccaaggat
ccacctcaccggcctcatccacatgaacttgtggggaaggactgccgggatggctactat
gaggctgacctctgcccagaccgcagtatccatagcttccagaacctggggatccagtgt
gtgaagaagcgagacctggagcaagccattagccagcgaatccagaccaacaataacccc
tttcacgttcctatagaggagcagcgcggggactatgacttgaatgcagtgcgcctctgc
ttccaggtgacagtgcgggacccagcaggcaggcccctcctcctgacccctgtcctctca
catccgatttttgataaccgggcccccaacactgccgagctcaagatctgccgagtaaac
cggaactctgggagctgcctcggtggggatgagatcttcttgctgtgcgacaaggtgcag
aaagaagacattgaggtgtatttcacgggaccaggctgggaggcacgaggctccttttct
caagctgatgtgcatcggcaagtggccattgtgttccggactcctccgtacgccgacccc
agcctccaggctcctgttcgagtctccatgcagctacggcggccttctgatcgcgagctc
agtgagcccatggagttccagtacttgccagacacagatgatcgccaccggattgaagag
aagcgcaaaaggacctatgagaccttcaagagtatcatgaagaagagtcctttcaatgga
ccaactgaaccccggcctccaacccggcgtattgctgtgcctacccgaaactcaacttct
gtccccaagccagccccgcagccctacaccttcccagcatccctcagcaccatcaacttt
gatgagttttcccccatgctgttaccatcagggcagatctcaaaccaggccctggccttg
gcaccgtcctctgccccagtccttgcccagaccatggtcccttcctcagccatggtacct
ctggctcagcccccagctcctgccccagttctaaccccgggtcctccccagtccctgtct
gcacctgttccaaagagcacccaggctggggaaggcacgctgtcggaagccctgctgcac
ctgcagtttgatgctgatgaagacttgggggccttgcttggcaacagcacagacccagga
gtgttcacagacctggcatctgtggacaactcagagtttcagcagctcctgaaccagggt
gtgtccatgtctcactccacagctgagcccatgctgatggagtaccctgaagctataact
cgcctggtgacagggtcccagaggccccctgacccagctcccacacccctggggacctcg
gggcttcccaatggtctctcaggagatgaagacttctcctccattgcggacatggacttc
tctgctcttttgagtcagatcagctcctaa
DBGET
integrated database retrieval system